Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Knowing what data is needed for financial analysis is crucial for accurate assessments. Gather the essential information to make informed financial decisions.
26,603 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
From Paris for VivaTech, Europe grapples with cybersecurity threats, sovereignty anxieties, and a strong push for ROI...
June’s stock market today saw Robinhood rise on the heels of an IPO underwriting announcement, signaling a potential ...
In 2026, a rising rate environment and tighter underwriting are driving HELOC denials. This report explains how to re...
With economic uncertainty builds rising and consumer costs stubborn, Dave Ramsey points to three core moves to weathe...
Imagine a beloved sneaker brand reinventing itself with AI and a bold rebrand. This speculative piece explores how su...
The national debt sits just shy of $39 trillion, days before national debt crosses the milestone. Markets are watchin...
Five Eyes partners warn that AI could outpace current cyber defenses, posing a risk to personal finances. This report...
Sam Altman declined interview requests for a high-profile AI documentary. The director answered by creating a Sam Bot...
Only a small slice of workers over 50 tap catch-up contributions in 2026, even with higher limits. Inflation, housing...
Jack Schlossberg issues a blunt warning to America’s CEOs: treat culture and AI-driven shifts as core business risks,...
Gauntlet, a veteran analytics provider in the DeFi space, secured $125 million from SBI Holdings in June, signaling g...